Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

ABVC ABVC BioPharma Inc

1,4402

-0,1498 (-9,42%)

27 Avr 2024 - Fermé

Retardé de 15 minutes

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Article too big to display. Click here to view on the SEC website

ABVC BioPharma (NASDAQ:ABVC)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024

Plus de graphiques de la Bourse ABVC BioPharma

ABVC BioPharma (NASDAQ:ABVC)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024

Plus de graphiques de la Bourse ABVC BioPharma

Actualités ABVC BioPharma Inc

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
Jeudi 18 Avril 2024 ( il y a 1 semaine) • GlobeNewswire Inc.

ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Mercredi 17 Avril 2024 ( il y a 1 semaine) • GlobeNewswire Inc.

ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
Mercredi 10 Avril 2024 ( il y a 2 semaines) • GlobeNewswire Inc.

ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
Mardi 26 Mars 2024 ( il y a 1 mois) • GlobeNewswire Inc.

AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
Jeudi 21 Mars 2024 ( il y a 1 mois) • GlobeNewswire Inc.

ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine
Mardi 19 Mars 2024 ( il y a 1 mois) • GlobeNewswire Inc.

ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
Jeudi 14 Mars 2024 ( il y a 1 mois) • GlobeNewswire Inc.

Form 8-K/A - Current report: [Amend]
Jeudi 29 Février 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Jeudi 29 Février 2024 ( il y a 2 mois) • Edgar (US Regulatory)

ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
Mardi 27 Février 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Vendredi 16 Février 2024 ( il y a 2 mois) • Edgar (US Regulatory)

ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
Jeudi 15 Février 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Plus d'articles sur ABVC BioPharma Inc

Cie de SaintGobain

JP Morgan Chase

Lvmh Moet Hennessy Louis...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales